Moxifran Eye Drops (Moxifloxacin Hydrochloride)

Adult dosage

1. Bacterial conjunctivitis, blepharitis, keratitis (including corneal ulcers): Instill 1 drop 3 times a day. Increase or decrease based on symptoms. 2. Sterilization therapy before and after ophthalmic surgery: Instill 1 drop 5 times a day before surgery, and 1 drop 3 times a day after surgery.

This medicine should not be injected directly into the eyes or the anterior chamber of the eye. Serious allergic reactions may occur in patients who have been administered systemic quinolone-based medications containing this drug. If any unusual symptoms arise, immediately discontinue use and seek emergency assistance. It should not be used in patients with allergies to this drug or similar components, or in infants under 1 year of age. Pregnant or nursing women should consult with their physician when considering the use of this medication. During use, symptoms such as inflammation, redness, pain, or itching in the eye may occur. If these symptoms become severe, consult a specialist. Prolonged use may result in other infections such as fungal infections, so discontinue use and seek alternative treatment if symptoms arise. Contact lens wear should be avoided when symptoms of bacterial conjunctivitis are present, and if any allergic reactions occur while using this medication, immediately discontinue and consult a physician. This medication is for ophthalmic use only, and care should be taken to prevent contamination of the tip of the container by contact with the eyes or fingers. If using other eye drops, a minimum interval of 5 minutes should be maintained between applications. Safety and efficacy have not been established for children, especially infants under 1 year of age, and use should be avoided. The medication can be used in the elderly without special caution. It should be stored in a cool place away from direct sunlight and kept out of reach of children. Long-term animal studies have not shown carcinogenicity; however, the risks and benefits to the fetus should be carefully considered when used during pregnancy. The secretion of this drug into breast milk is not known, so caution is required when used by nursing mothers.

Serious side effects

Hives, severe swelling (including angioedema, swelling of pharynx, larynx, and face), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, respiratory distress, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme drowsiness, liver abnormalities (jaundice), sudden onset.

Mild side effects

Conjunctivitis, decreased vision, dry eyes, keratitis, eye discomfort, eye redness, eye pain, itching, subconjunctival hemorrhage, tearing, fever, cough, infection, otitis media, pharyngitis, redness, rhinitis, eye pain, taste disturbance, eye irritation, eyelid edema, blurred vision, sensory anomalies at the application site, atrial fibrillation, dizziness, endophthalmitis, ulcerative keratitis, corneal erosion, corneal abrasion, increased intraocular pressure, corneal opacity, corneal infiltrate, corneal deposits, allergies.

This medication should be stored in a sealed container to avoid exposure to air or moisture. It is best to maintain storage temperatures between 1°C and 30°C.

Appearance

A pale yellow-green transparent solution in a colorless translucent plastic container.

Package unit

6mL